Cargando…

The Punicalagin Metabolites Ellagic Acid and Urolithin A Exert Different Strengthening and Anti-Inflammatory Effects on Tight Junction-Mediated Intestinal Barrier Function In Vitro

Scope: Ellagitannins are polyphenols found in numerous fruits, nuts and seeds. The elagitannin punicalagin and its bioactive metabolites ellagic acid and urolithins are discussed to comprise a high potential for therapeutically or preventive medical application such as in intestinal diseases. The pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Hering, Nina A., Luettig, Julia, Jebautzke, Britta, Schulzke, Jörg D., Rosenthal, Rita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987831/
https://www.ncbi.nlm.nih.gov/pubmed/33776763
http://dx.doi.org/10.3389/fphar.2021.610164
_version_ 1783668678201442304
author Hering, Nina A.
Luettig, Julia
Jebautzke, Britta
Schulzke, Jörg D.
Rosenthal, Rita
author_facet Hering, Nina A.
Luettig, Julia
Jebautzke, Britta
Schulzke, Jörg D.
Rosenthal, Rita
author_sort Hering, Nina A.
collection PubMed
description Scope: Ellagitannins are polyphenols found in numerous fruits, nuts and seeds. The elagitannin punicalagin and its bioactive metabolites ellagic acid and urolithins are discussed to comprise a high potential for therapeutically or preventive medical application such as in intestinal diseases. The present study characterizes effects of punicalagin, ellagic acid and urolithin A on intestinal barrier function in the absence or presence of the proinflammatory cytokine tumor necrosis factor-α (TNFα). Methods and Results: Transepithelial resistance (TER), fluorescein and ion permeability, tight junction protein expression and signalling pathways were examined in Caco-2 and HT-29/B6 intestinal epithelial cell models. Punicalagin had less or no effects on barrier function in both cell models. Ellagic acid was most effective in ileum-like Caco-2 cells, where it increased TER and reduced fluorescein and sodium permeabilities. This was paralleled by myosin light chain kinase two mediated expression down-regulation of claudin-4, -7 and -15. Urolithin A impeded the TNFα-induced barrier loss by inhibition of claudin-1 and -2 protein expression upregulation and claudin-1 delocalization in HT-29/B6. Conclusion: Ellagic acid and urolithin A affect intestinal barrier function in distinct ways. Ellagic acid acts preventive by strengthening the barrier per se, while urolithin A protects against inflammation-induced barrier dysfunction.
format Online
Article
Text
id pubmed-7987831
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-79878312021-03-25 The Punicalagin Metabolites Ellagic Acid and Urolithin A Exert Different Strengthening and Anti-Inflammatory Effects on Tight Junction-Mediated Intestinal Barrier Function In Vitro Hering, Nina A. Luettig, Julia Jebautzke, Britta Schulzke, Jörg D. Rosenthal, Rita Front Pharmacol Pharmacology Scope: Ellagitannins are polyphenols found in numerous fruits, nuts and seeds. The elagitannin punicalagin and its bioactive metabolites ellagic acid and urolithins are discussed to comprise a high potential for therapeutically or preventive medical application such as in intestinal diseases. The present study characterizes effects of punicalagin, ellagic acid and urolithin A on intestinal barrier function in the absence or presence of the proinflammatory cytokine tumor necrosis factor-α (TNFα). Methods and Results: Transepithelial resistance (TER), fluorescein and ion permeability, tight junction protein expression and signalling pathways were examined in Caco-2 and HT-29/B6 intestinal epithelial cell models. Punicalagin had less or no effects on barrier function in both cell models. Ellagic acid was most effective in ileum-like Caco-2 cells, where it increased TER and reduced fluorescein and sodium permeabilities. This was paralleled by myosin light chain kinase two mediated expression down-regulation of claudin-4, -7 and -15. Urolithin A impeded the TNFα-induced barrier loss by inhibition of claudin-1 and -2 protein expression upregulation and claudin-1 delocalization in HT-29/B6. Conclusion: Ellagic acid and urolithin A affect intestinal barrier function in distinct ways. Ellagic acid acts preventive by strengthening the barrier per se, while urolithin A protects against inflammation-induced barrier dysfunction. Frontiers Media S.A. 2021-03-10 /pmc/articles/PMC7987831/ /pubmed/33776763 http://dx.doi.org/10.3389/fphar.2021.610164 Text en Copyright © 2021 Hering, Luettig, Jebautzke, Schulzke and Rosenthal. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Hering, Nina A.
Luettig, Julia
Jebautzke, Britta
Schulzke, Jörg D.
Rosenthal, Rita
The Punicalagin Metabolites Ellagic Acid and Urolithin A Exert Different Strengthening and Anti-Inflammatory Effects on Tight Junction-Mediated Intestinal Barrier Function In Vitro
title The Punicalagin Metabolites Ellagic Acid and Urolithin A Exert Different Strengthening and Anti-Inflammatory Effects on Tight Junction-Mediated Intestinal Barrier Function In Vitro
title_full The Punicalagin Metabolites Ellagic Acid and Urolithin A Exert Different Strengthening and Anti-Inflammatory Effects on Tight Junction-Mediated Intestinal Barrier Function In Vitro
title_fullStr The Punicalagin Metabolites Ellagic Acid and Urolithin A Exert Different Strengthening and Anti-Inflammatory Effects on Tight Junction-Mediated Intestinal Barrier Function In Vitro
title_full_unstemmed The Punicalagin Metabolites Ellagic Acid and Urolithin A Exert Different Strengthening and Anti-Inflammatory Effects on Tight Junction-Mediated Intestinal Barrier Function In Vitro
title_short The Punicalagin Metabolites Ellagic Acid and Urolithin A Exert Different Strengthening and Anti-Inflammatory Effects on Tight Junction-Mediated Intestinal Barrier Function In Vitro
title_sort punicalagin metabolites ellagic acid and urolithin a exert different strengthening and anti-inflammatory effects on tight junction-mediated intestinal barrier function in vitro
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987831/
https://www.ncbi.nlm.nih.gov/pubmed/33776763
http://dx.doi.org/10.3389/fphar.2021.610164
work_keys_str_mv AT heringninaa thepunicalaginmetabolitesellagicacidandurolithinaexertdifferentstrengtheningandantiinflammatoryeffectsontightjunctionmediatedintestinalbarrierfunctioninvitro
AT luettigjulia thepunicalaginmetabolitesellagicacidandurolithinaexertdifferentstrengtheningandantiinflammatoryeffectsontightjunctionmediatedintestinalbarrierfunctioninvitro
AT jebautzkebritta thepunicalaginmetabolitesellagicacidandurolithinaexertdifferentstrengtheningandantiinflammatoryeffectsontightjunctionmediatedintestinalbarrierfunctioninvitro
AT schulzkejorgd thepunicalaginmetabolitesellagicacidandurolithinaexertdifferentstrengtheningandantiinflammatoryeffectsontightjunctionmediatedintestinalbarrierfunctioninvitro
AT rosenthalrita thepunicalaginmetabolitesellagicacidandurolithinaexertdifferentstrengtheningandantiinflammatoryeffectsontightjunctionmediatedintestinalbarrierfunctioninvitro
AT heringninaa punicalaginmetabolitesellagicacidandurolithinaexertdifferentstrengtheningandantiinflammatoryeffectsontightjunctionmediatedintestinalbarrierfunctioninvitro
AT luettigjulia punicalaginmetabolitesellagicacidandurolithinaexertdifferentstrengtheningandantiinflammatoryeffectsontightjunctionmediatedintestinalbarrierfunctioninvitro
AT jebautzkebritta punicalaginmetabolitesellagicacidandurolithinaexertdifferentstrengtheningandantiinflammatoryeffectsontightjunctionmediatedintestinalbarrierfunctioninvitro
AT schulzkejorgd punicalaginmetabolitesellagicacidandurolithinaexertdifferentstrengtheningandantiinflammatoryeffectsontightjunctionmediatedintestinalbarrierfunctioninvitro
AT rosenthalrita punicalaginmetabolitesellagicacidandurolithinaexertdifferentstrengtheningandantiinflammatoryeffectsontightjunctionmediatedintestinalbarrierfunctioninvitro